Skip to main content
. 2009 Feb;15(2):163–168. doi: 10.3201/eid1502.071269

Table 1. Properties of Vibrio parahaemolyticus clinical isolates from Puerto Montt, Chile, summer 2007*.

Isolate tlh tdh trh orf8 ToxRS/new Serotype DGREA group MLST ST†
PMC50.7, 51.7, 41.7, 72.7, 1.7, 15.7, 16.7 + + + + O3:K6 VpKX 3
PMC55.7, 56.7, 58.7, 28.7, 44.7, 73.7, 14.7, 18.7 + + + + O3:K59 VpKX ND
PMC29.7, 42.7, 70.7, 11.7, 19.7 + + + + O3:K6,59 VpKX ND
PMC59.7, 63.7, 64.7, 65.7, 66.7, 20.7, 22.7 + + + + ND VpKX ND
PMC38.7, 47.7, 57.7, 68.7 + + O10:K20 38.7 63
PMC60.7, 25.7, 26.7, 27.7 + + + O1:KUT 60.7 64
PMC53.7 + O3:K59 1.5 28
PMC75.7 + O1:KUT 75.7 65

*Isolates with an undetermined serotype are in boldface. orf, open reading frame; DGREA, direct genome restriction enzyme analysis; MLST, multilocus sequence typing; ST, sequence type; ND, not determined.
†Sequences are available from http://pubmlst.org/vparahaemolyticus.